We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Hyperimmune anti-HBs plasma as alternative tocommercial immunoglobulins for prevention ofHBV recurrence after liver transplantation.
- Authors
Bihl, Florian; Russmann, Stefan; Gurtner, Vanina; Di Giammarino, Loriana; Pizzi-Bosman, Loredana; Michel, Martine; Cerny, Andreas; Hadengue, Antoine; Majno, Pietro; Giostra, Emiliano; Castelli, Damiano; Mentha, Gilles
- Abstract
Background: Hepatitis B immune globulins (HBIG) in combination with nucleos(t)ide analogues (NA) are effectively used for the prevention of hepatitis B virus (HBV) recurrence after liver transplantation (LT). However, associated treatment costs for HBIG are exceedingly high. Methods: Fresh frozen plasma obtained from blood donors with high anti-HBs levels (hyperimmune plasma, HIP) containing at least 4,500 IU anti-HBs was used as alternative treatment for HBV recurrence prophylaxis post-LT. Results: Twenty-one HBV-related LT recipients received HIP starting at transplantation, followed by long-term combination treatment with NA. Mean follow-up time was 4.5 years (range 0.5-12.6) and each patient received on average 8.2 HIP per year (range 5.8-11.4). Anti-HBs terminal elimination kinetic after HIP administration was 20.6 days (range 13.8-30.9), which is comparable to values reported for commercial HBIG products. All 21 patients remained free of HBV recurrence during follow-up and no transfusion-transmitted infection or other serious complication was observed. Seven patients developed reversible mild transfusion reactions. The cost for one HIP unit was US$140; average yearly HBIG treatment cost was US$1,148 per patient, as compared to US$25,000-100,000 for treatment with commercial HBIG. Conclusion: The results of this study suggest that the use of HIP may be a useful and economical approach for the prevention of HBV recurrence post-LT if used in combination with NA. Additional prospective controlled studies in larger populations are needed to confirm these results.
- Subjects
HEPATITIS B prevention; LIVER transplantation; NUCLEOSIDES; BLOOD plasma; BLOOD donors
- Publication
BMC Gastroenterology, 2010, Vol 10, p71
- ISSN
1471-230X
- Publication type
Article
- DOI
10.1186/1471-230X-10-71